Lalimos, Luela C.

HRN: 27-53-89  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/04/2025
08/11/2025
IV
250 Mg
OD
Klebsiella Pneumoniae Infection
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines